Skip to main content
Erschienen in: Rheumatology International 3/2019

17.01.2019 | Public Health

Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system

Erschienen in: Rheumatology International | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

The study objective was to estimate secular trends in the overall incidence rate (IR) and prevalence rate (PR) of rheumatoid arthritis (RA); and subgroup-specific IR and PR by race, ethnicity, and sex in a multi-ethnic population of a large integrated health care delivery system. An ecological study was conducted within the adult population of Kaiser Permanente Southern California health plan. From January 1995 up to and including December 2014, annual IR and PR were calculated separately by race, ethnicity, sex and pooled overall. Depending on the stationarity of each ecological series, annual percentage change in IR and PR was evaluated using auto-regressive integrated moving average models. Average overall IR was 53 [95% confidence interval (CI) 46, 61] per 100,000 person-years. The overall as well as subgroup-specific annual IR of RA were unchanged from 1995 to 2014. In 1995, the overall PR of RA was 59 (44, 74) per 100,000 person-years which increased by 14% (7%, 21%) annually thereafter. The increase in PR in Caucasians was lower as compared to African American, Asian and other race (13% vs 15%, 15%, and 18%, respectively). Compared to non-Hispanic ethnicity, the increase in PR among Hispanic was higher (17% vs 14%). Over the past 2 decades, while the incidence of RA was unchanged, the prevalence had increased significantly overall as well as within every subgroup of race, ethnicity, and sex.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15–25CrossRef Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15–25CrossRef
2.
Zurück zum Zitat Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2010) Is the incidence of rheumatoid arthritis rising? Results from Olmsted County. Arthritis Rheum 62(6):1576–82 (Minnesota, 1955–2007) CrossRefPubMedPubMedCentral Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2010) Is the incidence of rheumatoid arthritis rising? Results from Olmsted County. Arthritis Rheum 62(6):1576–82 (Minnesota, 1955–2007) CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Jean S, Hudson M, Gamache P et al (2017) Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clin Rheumatol Jean S, Hudson M, Gamache P et al (2017) Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clin Rheumatol
4.
Zurück zum Zitat Dadoun S, Zeboulon-Ktorza N, Combescure C et al (2013) Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint, bone, spine: revue du rhumatisme 80(1):29–33CrossRef Dadoun S, Zeboulon-Ktorza N, Combescure C et al (2013) Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint, bone, spine: revue du rhumatisme 80(1):29–33CrossRef
5.
Zurück zum Zitat Koebnick C, Langer-Gould AM, Gould MK et al (2012) Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Permanente J 16(3):37–41CrossRef Koebnick C, Langer-Gould AM, Gould MK et al (2012) Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Permanente J 16(3):37–41CrossRef
6.
Zurück zum Zitat Granger CWJ, Newbold P (1974) Spurious regressions in econometrics. J Econ 2:111–120CrossRef Granger CWJ, Newbold P (1974) Spurious regressions in econometrics. J Econ 2:111–120CrossRef
7.
Zurück zum Zitat Phillips PCB (1986) Understanding spurious regressions in econometrics. J Econ 33:311–340CrossRef Phillips PCB (1986) Understanding spurious regressions in econometrics. J Econ 33:311–340CrossRef
8.
Zurück zum Zitat Box GEP, Jenkins GM (1970) Time series analysis: forecasting and control. Holden-Day, San Francisco Box GEP, Jenkins GM (1970) Time series analysis: forecasting and control. Holden-Day, San Francisco
9.
Zurück zum Zitat Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI (2013) Time trends of incidence of age-associated diseases in the US elderly population: medicare-based analysis. Age Ageing 42(4):494–500CrossRefPubMedPubMedCentral Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI (2013) Time trends of incidence of age-associated diseases in the US elderly population: medicare-based analysis. Age Ageing 42(4):494–500CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA (2016) Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation Among US adults, 2015–2040. Arthritis Rheumatol 68(7):1582–1587CrossRefPubMedPubMedCentral Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA (2016) Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation Among US adults, 2015–2040. Arthritis Rheumatol 68(7):1582–1587CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM (2013) Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum 65(2):334–342CrossRefPubMedPubMedCentral Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM (2013) Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum 65(2):334–342CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ajeganova S, Andersson ML, Frostegard J, Hafstrom I (2013) Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol Ajeganova S, Andersson ML, Frostegard J, Hafstrom I (2013) Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol
13.
Zurück zum Zitat Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Therapy 11(3):229CrossRef Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Therapy 11(3):229CrossRef
14.
Zurück zum Zitat Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52(3):722–732CrossRefPubMed Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52(3):722–732CrossRefPubMed
15.
Zurück zum Zitat Chu LH, Portugal C, Kawatkar AA, Stohl W, Nichol MB (2013) Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res 65(2):299–303CrossRef Chu LH, Portugal C, Kawatkar AA, Stohl W, Nichol MB (2013) Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res 65(2):299–303CrossRef
16.
Zurück zum Zitat Kawatkar AA, Hay JW, Stohl W, Nichol MB (2013) Incremental expenditure of biologic disease modifying antirheumatic treatment using instrumental variables in panel data. Health Econ 22(7):807–823CrossRefPubMed Kawatkar AA, Hay JW, Stohl W, Nichol MB (2013) Incremental expenditure of biologic disease modifying antirheumatic treatment using instrumental variables in panel data. Health Econ 22(7):807–823CrossRefPubMed
17.
Zurück zum Zitat Ezzati M, Riboli E (2013) Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med 369(10):954–964CrossRef Ezzati M, Riboli E (2013) Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med 369(10):954–964CrossRef
18.
Zurück zum Zitat Demoruelle MK, Deane KD (2012) Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep 14(5):472–480CrossRefPubMedPubMedCentral Demoruelle MK, Deane KD (2012) Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep 14(5):472–480CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF (2013) Drug therapy in undifferentiated arthritis: a systematic literature review. Ann Rheum Dis 72(9):1436–1444CrossRefPubMed Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF (2013) Drug therapy in undifferentiated arthritis: a systematic literature review. Ann Rheum Dis 72(9):1436–1444CrossRefPubMed
20.
Zurück zum Zitat Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188CrossRefPubMed Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188CrossRefPubMed
21.
Zurück zum Zitat Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW (2008) Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med 168(15):1664–1670CrossRefPubMedPubMedCentral Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW (2008) Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med 168(15):1664–1670CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kaipiainen-Seppanen O, Kautiainen H (2006) Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980–2000. J Rheumatol 33(11):2132–2138PubMed Kaipiainen-Seppanen O, Kautiainen H (2006) Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980–2000. J Rheumatol 33(11):2132–2138PubMed
23.
Zurück zum Zitat Pedersen JK, Kjaer NK, Svendsen AJ, Horslev-Petersen K (2009) Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatol Int 29(4):411–415CrossRefPubMed Pedersen JK, Kjaer NK, Svendsen AJ, Horslev-Petersen K (2009) Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatol Int 29(4):411–415CrossRefPubMed
24.
Zurück zum Zitat Pedersen JK, Svendsen AJ, Horslev-Petersen K (2007) Incidence of Rheumatoid Arthritis in the southern part of Denmark from 1995 to 2001. Open Rheumatol J 1:18–23CrossRefPubMedPubMedCentral Pedersen JK, Svendsen AJ, Horslev-Petersen K (2007) Incidence of Rheumatoid Arthritis in the southern part of Denmark from 1995 to 2001. Open Rheumatol J 1:18–23CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Rodriguez LA, Tolosa LB, Ruigomez A, Johansson S, Wallander MA (2009) Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol 38(3):173–177CrossRefPubMed Rodriguez LA, Tolosa LB, Ruigomez A, Johansson S, Wallander MA (2009) Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol 38(3):173–177CrossRefPubMed
26.
Zurück zum Zitat MacGregor AJ, Silman AJ (1992) A reappraisal of the measurement of disease occurrence in rheumatoid arthritis. J Rheumatol 19(8):1163–1165PubMed MacGregor AJ, Silman AJ (1992) A reappraisal of the measurement of disease occurrence in rheumatoid arthritis. J Rheumatol 19(8):1163–1165PubMed
27.
Zurück zum Zitat Minichiello E, Semerano L, Boissier MC (2016) Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review. Joint, Bone, Spine: revue du rhumatisme 83(6):625–630CrossRef Minichiello E, Semerano L, Boissier MC (2016) Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review. Joint, Bone, Spine: revue du rhumatisme 83(6):625–630CrossRef
28.
Zurück zum Zitat Englund M, Joud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF (2010) Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology 49(8):1563–1569CrossRefPubMed Englund M, Joud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF (2010) Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology 49(8):1563–1569CrossRefPubMed
29.
Zurück zum Zitat Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J (2013) Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res 65(6):870–878CrossRef Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J (2013) Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res 65(6):870–878CrossRef
30.
Zurück zum Zitat Odegard S, Kvien TK, Uhlig T (2008) Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis. J Rheumatol 35(1):54–60PubMed Odegard S, Kvien TK, Uhlig T (2008) Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis. J Rheumatol 35(1):54–60PubMed
Metadaten
Titel
Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system
Publikationsdatum
17.01.2019
Erschienen in
Rheumatology International / Ausgabe 3/2019
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-04235-y

Weitere Artikel der Ausgabe 3/2019

Rheumatology International 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.